MG
Marex Group Portfolio holdings
AUM
$23.6B
Turnover
47.63%
1-Year Est. Return
57.16%
This Fund
S&P 500
This Quarter
Est. Return
+4.95%
1 Year Est. Return
+57.16%
3 Year Est. Return
+254.23%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.8B
AUM Growth
-$67.5M
(-0.42%)
Cap. Flow
+$1.48B
Cap. Flow
% of AUM
9.36%
Top 10 Holdings %
Top 10 Hldgs %
30.69%
Holding
1,298
New
335
Increased
347
Reduced
276
Closed
290
Avg Time Held Equity + Options
0.7
years
Top 10 Avg Time Held Equity + Options
0.2
years
Top 20 Avg Time Held Equity + Options
0.5
years
Avg Time Held Equity only
0.7
years
Top 10 Avg Time Held Equity only
0.6
years
Top 20 Avg Time Held Equity only
0.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Lumentum
LITE
|
+$471M |
| 2 |
Sandisk
SNDK
|
+$313M |
| 3 |
Goldman Sachs
GS
|
+$179M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$144M |
| 5 |
Eli Lilly
LLY
|
+$113M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$304M |
| 2 |
UnitedHealth
UNH
|
+$174M |
| 3 |
NVIDIA
NVDA
|
+$137M |
| 4 |
Home Depot
HD
|
+$131M |
| 5 |
Netflix
NFLX
|
+$107M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.11% |
| 2 | Technology | 25% |
| 3 | Financials | 9.44% |
| 4 | Consumer Discretionary | 4.76% |
| 5 | Healthcare | 4.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
976
Beyond Meat
BYND
$117M
| $39.7K | ﹤0.01% |
1,886
+517
| +38% | +$12.4K |
2025 Q4
1 quarter
|
|
977
Datavault AI
DVLT
$117M
| $37.1K | ﹤0.01% |
60,000
-123,000
| -67% | -$93.3K |
2025 Q3
2 quarters
|
|
978
iQIYI
IQ
$919M
| $37.1K | ﹤0.01% |
27,471
+4,600
| +20% | +$7.94K |
2022 Q4
13 quarters
|
|
979
Sidus Space
SIDU
$126M
| $34.5K | ﹤0.01% |
+14,882
| New | +$40.5K |
2026 Q1
0 quarters
|
|
980
W&T Offshore
WTI
$560M
| $34.1K | ﹤0.01% |
+10,000
| New | +$24.7K |
2026 Q1
0 quarters
|
|
981
Bit Digital
BTBT
$386M
| $33.2K | ﹤0.01% |
25,368
-10,000
| -28% | -$18.4K |
2025 Q3
2 quarters
|
|
982
SEALSQ Corp
LAES
$430M
| $28K | ﹤0.01% |
+10,705
| New | +$41.8K |
2026 Q1
0 quarters
|
|
983
Acrivon Therapeutics
ACRV
$75.4M
| $27.8K | ﹤0.01% |
20,000
+10,000
| +100% | +$17.4K |
2025 Q4
1 quarter
|
|
984
The GrowHub Ltd
TGHL
$17.4M
| $22.3K | ﹤0.01% |
77,727
-6,000
| -7% | -$2.23K |
2025 Q3
2 quarters
|
|
985
Tantech Holdings
TANH
$8.9M
| $20.1K | ﹤0.01% |
682
-277
| -29% | -$12.3K |
2025 Q2
3 quarters
|
|
986
Intchains Group
ICG
$80.2M
| $18.6K | ﹤0.01% |
15,122
+3,122
| +26% | +$4.88K |
2025 Q1
4 quarters
|
|
987
Filana Therapeutics
FLNA
$34.8M
| $17.7K | ﹤0.01% |
+10,500
| New | +$21.6K |
2026 Q1
0 quarters
|
|
988
Canaan Creative
CAN
$187M
| $17.3K | ﹤0.01% |
40,000
| – | – |
2025 Q4
1 quarter
|
|
|
KUST
989
Kustom Entertainment Inc
KUST
$2.44M
| $15.7K | ﹤0.01% |
+539
| New | +$38.7K |
2026 Q1
0 quarters
|
|
990
Fractyl Health
GUTS
$52.9M
| $13.5K | ﹤0.01% |
+2,461
| New | +$27.2K |
2026 Q1
0 quarters
|
|
991
AI Financial Corp
AIFC
$56.2M
| $12.8K | ﹤0.01% |
11,541
-80,557
| -87% | -$131K |
2025 Q3
2 quarters
|
|
992
Alta Global Group
MMA
$9.67M
| $12.2K | ﹤0.01% |
27,000
| – | – |
2025 Q3
2 quarters
|
|
993
Blink Charging
BLNK
$65.5M
| $11.3K | ﹤0.01% |
20,000
| – | – |
2023 Q4
9 quarters
|
|
994
Eightco Holdings
ORBS
$331M
| $9.6K | ﹤0.01% |
+10,300
| New | +$13.2K |
2026 Q1
0 quarters
|
|
995
New Fortress Energy
NFE
$21.9M
| $9.1K | ﹤0.01% |
+308
| New | +$18K |
2026 Q1
0 quarters
|
|
996
AleAnna Inc Warrant
ANNAW
$9.78M
| $8.1K | ﹤0.01% |
+10,000
| New | +$3.07K |
2026 Q1
0 quarters
|
|
997
Propanc Biopharma
PPCB
$3.91M
| $7.18K | ﹤0.01% |
2,709
+108
| +4% | +$641 |
2025 Q3
2 quarters
|
|
998
QTREX Quantum
QTEX
$95.2M
| $4.94K | ﹤0.01% |
+11,061
| New | +$7.49K |
2026 Q1
0 quarters
|
|
999
Foxx Development Holdings Warrant
FOXXW
$533K
| $1.3K | ﹤0.01% |
15,000
-11,000
| -42% | -$1.34K |
2025 Q4
1 quarter
|
|
1000
MoneyHero Ltd Warrants
MNYWW
$399K
| $850 | ﹤0.01% |
11,320
| – | – |
2023 Q4
9 quarters
|
|
Similar funds
AF
NAM
ATO
DSA
A
Marex Group's Q1 2026 Portfolio in Review
As of Q1 2026, Marex Group held 1,298 positions worth $15.8B, down 0.42% from $15.9B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Marex Group deployed $1.48B of net new capital in Q1 2026, opening 335 new positions and adding to 347 existing holdings. Its largest new stake was Lumentum: 857,171 shares worth $602M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 51% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $304M trimmed.
- Marex Group's largest Q1 2026 buy was Lumentum: 857,171 shares worth $602M.
- Marex Group added most to Goldman Sachs in Q1 2026, an estimated $179M increase.
- Marex Group's biggest Q1 2026 reduction was Meta Platforms (Facebook), cutting an estimated $304M.
- Marex Group fully exited Dycom Industries in Q1 2026, selling an estimated $13.3M.
- Marex Group's ten largest holdings make up 31% of its $15.8B portfolio in Q1 2026.
- Marex Group opened 335 new positions and closed 290 in Q1 2026.
- Marex Group's portfolio value fell 0.42% quarter-over-quarter to $15.8B.
Based on Marex Group's 13F filing for Q1 2026, filed 13 May 2026.